Loading stock data…
Kimberly-Clark Corporation (KMB)
$102.93-2.03 (-1.93%)
Market ClosedLast close Sep 8
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care products in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Kimberly-Clark Corporation in the Consumer Defensive sector is trading at $102.93 with a market capitalization of $34.9B. Wall Street consensus targets $118.60 (15 analysts), implying a +15.2% move over the next 12 months. The stock is currently 21% below its 52-week high of $130.83, remaining 2.3% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +15.2% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $4.19B↑ | $4.16B↑ | $4.08B↓ | $4.15B↓ | $4.16B |
| Gross Profit | $1.60B↑ | $1.53B↑ | $1.47B↓ | $1.49B↑ | $1.46B |
| Operating Income | $633.00M↓ | $753.00M↑ | $507.00M↓ | $621.00M↑ | $592.00M |
| Net Income | $345.00M↓ | $665.00M↑ | $499.00M↑ | $446.00M↓ | $509.00M |
Peer Comparison
Fundamentals
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care products in the United States. It operates in two segments, North America and International Personal Care. The North America segment offers disposable ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$34.91B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
20.74
Beta
Defensive asset. Lower volatility than the S&P 500.
0.27
Div Yield
Strong income play. Yield provides a meaningful total return floor.
3.71%
ROE
Elite ROE. Management converts capital into profit efficiently.
111.71%
Volume
Today's trading volume
3.29M
Recent News
Can Kimberly-Clark Turn its $40 Billion Kenvue Bet into $2.1 Billion in Savings?
Kimberly-Clark Corporation’s (NASDAQ:KMB) proposed $40 billion takeover of Kenvue has entered another stage of regulatory review. Documents on the European Commission’s website show that Kimberly-Clark has requested EU permission to complete the transaction, which was first announced in November 2025. The deal would combine Kimberly-Clark (NASDAQ:KMB) with a large portfolio of consumer-health brands, including Tylenol, […]
Altria Is Spending More on Capex Than Any Other Consumer Staples Name. It’s a Calculated Sign of Strength.
Altria’s capex jump looks more like a strategic investment than a warning.
Kenvue's Kimberly-Clark Deal Nears Closing With Key Risks Still Ahead
KVUE nears its planned combination after shareholder and U.S. antitrust clearances, while margin, debt and legal risks temper the Q4 2026 outlook.
Can Kimberly-Clark's Innovation Pipeline Power Its Next Growth Phase?
KMB is banking on science-backed innovation, stronger value propositions and a deep product pipeline to drive future growth.
4 Battle-Tested Consumer Staples Stocks That Keep Raising Their Dividends
Some dividend stocks fold the moment a recession hits, but four consumer staples names kept raising their payouts straight through a housing collapse and a global lockdown without missing a beat. The question now is whether their current yields and margins make them worth owning before the next ugly year arrives.